4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-000169
Chief Operating Officer gave up 1,406 shares (to pay taxes)
- Chief Operating Officer acquired 4,062 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2022-12-31 | Option exercise | +4,062 | 28,300 | D: show line 1 in the form | ||
| Cittadine Andrew Chief Operating Officer | 2022-12-31 | Shares withheld for taxes | −1,406 | $2.37 | $3,332 | 26,894 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2022-12-31 | Option exercise · Restricted Stock Units | −4,062 | 48,750 | D: show line 3 in the form |
Loading xslF345X03/rdgdoc.xml…